Boston Scientific Strikes Back In Stent Trial
With trial ongoing, Boston Scientific Corp. is seeking judgment as a matter of law in its battle with Cordis Corp. over stent patents, arguing that no reasonable juror could find in...To view the full article, register now.
Already a subscriber? Click here to view full article